Ovarian Cancer
Ovarian Borderline Tumors
GYOEDU Resident: Ovarian Cancer Surveillance and Recurrences
HIPEC in ovarian cancer
Korean HIPEC trial
The addition of HIPEC after interval cytoreductive surgery following neoadjuvant chemotherapy provided significant improvements in PFS and OS.
Mucinous Ovarian Carcinoma
GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer
Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.